These findings underscore the importance of glycemic control in at‐risk populations as a potential strategy to mitigate AD development, with emerging evidence suggesting that early metabolic interventions may preserve cognitive function by maintaining proper insulin signaling in vulnerable brain regions (Nguyen et al. 2020). This evidence concerns the gene INS and Alzheimer disease.